Clinical evaluation and staging of patients who have lung cancer.
This article updates the performance characteristics of the most commonly used diagnostic and staging modalities in the evaluation of a patient who has lung cancer. Recent data with newer modalities, like positron emission tomography, are reviewed, and their role in this evaluation is discussed.
['Carcinoma, Non-Small-Cell Lung/diagnosis/pathology', 'Carcinoma, Small Cell/diagnosis/pathology', 'Fluorodeoxyglucose F18', 'Humans', 'Lung Neoplasms/*diagnosis/*pathology', 'Neoplasm Staging', 'Positron-Emission Tomography']